In Vitro Diagnostics Market to Witness Robust Expansion by 2028
Stratview Research has published a new report titled “In Vitro Diagnostics Market” which is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Others), by Product Type (Instruments, Reagents, and Others), by Usability Type (Disposable IVD Devices and Reusable IVD Devices), by Application Type (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), by End-User Type (Diagnostic Laboratories, Hospitals and Clinics, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
As per the study, the market is expected to grow from USD 100.49 billion in 2021 to reach USD 121.09 billion by 2028 at a healthy CAGR of 2.7% during the forecast period of 2022-2028.
In vitro diagnostics are ****s that are performed on blood samples or tissues that have been taken from the human body, to detect, treat, and prevent diseases.
Read more: https://www.stratviewresearch.....com/2595/In-Vitro-Di
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry’s market dynamics. It thoroughly analyzes the market segments, including products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
By Test Type
The Molecular Diagnostics segment accounted for the largest market share of >37.5% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
The market is segmented into Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Others.
By Product Type
The Reagents segment accounted for the largest market share of >64.50% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
The market is segmented into instruments, reagents, and others. Increasing need for reagents to meet the growing demand for diagnostics across the world, for the diagnosis of COVID-19 infection.
By End-User Type:
The Diagnostic Laboratories segment accounted for the largest market share of >37.50% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
The market is segmented into Diagnostic Laboratories, Hospitals and Clinics, and Others. Major growth factors of the laboratory segment are the growing demand for affordable services, technological advancements, and a rapid increase in awareness about personalized medicines.
By Application Type:
The Infectious Disease segment accounted for the largest market share of >59% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
The market is segmented into Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others. The detection of microorganisms or disease-causing bacteria is facilitated by IVDs. HIV/AIDS, TB, hepatitis, and pneumonia are the most frequently occurring life-threatening illnesses.
Which Region is expected to remain the largest market?
North America accounted for the largest market share of >41.50% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
It is estimated to be the dominating region in the market over the forecast period on account of its well-established healthcare industry, rising prevalence of chronic diseases in the region, presence of some of the market's major players, and an increasing number of product launches. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Who are the Key Players in the Market?
This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, enabling strategic decision-making for the existing market players and those willing to enter the market. The following are the key players acting in the In Vitro Diagnostics Market:
• Abbott Laboratories
• Arkray Inc.
• Becton, Dickinson, and Company
• Biomerieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• Sysmex Corporation
• Thermo Fischer Scientific Inc.
Key questions answered by the report.
• What is the projected CAGR for revenue from the In Vitro Diagnostics Market during the forecast period?
• What would the market be valued at by 2028?
• What is a major driving factor for the growth of the market?
• Which region accounted for the largest revenue share in the In Vitro Diagnostics Market?
• Which are the major market players?
Custom Research:
Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to [email protected]. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports and growth consulting services. Our business intelligence and industry research reports offer clients insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
